TROGARZO® RECEIVES POSITIVE RECOMMENDATION FROM THE CHMP IN EUROPE

2019-07-16

The Committee for Medicinal Products for Human use (CHMP) in Europe has given a positive recommendation for the approval of Trogarzo® (ibalizumab) for the treatment of Multidrug Resistant HIV-1.

 

This positive opinion will now be taken into consideration by the European Commission (EC) which will issue a final decision in the near future.